MedTrace Logo

Study of Stereotactic Radiotherapy for Breast Cancer

NCT03043794 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

This is a Phase II trial of preoperative stereotactic radiation to the breast for low risk breast cancer.

Conditions

Interventions

RADIATION

Stereotactic Body Radiation Therapy SBRT

Stereotactic Body Radiation Therapy to the breast to 21 Gy

Sponsors & Collaborators

  • Robert L. Sloan Fund for Cancer Research

    collaborator OTHER

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Jean Wright, MD · Johns Hopkins University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2021-10-20
Completion
2023-10-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043794 on ClinicalTrials.gov